KMT2A and neoplasm: Tumor cell proliferation (BrdU-labeling index) was not significantly different between the groups (PBS; 32.7 ± 3.1%, G-EVs; 36.6 ± 2.2% and MLL-EVs; 37.0 ± 2.1%, mean ± SEM, P = 0.74).